suplatast tosilate has been researched along with histamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurokawa, I; Mizutani, H; Murakami, T; Nakanishi, K; Tokime, K; Tsutsui, H; Yamanaka, K | 1 |
| Fukui, H; Hattori, M; Horio, S; Kitamura, Y; Maeyama, K; Mizuguchi, H; Orimoto, N; Shahriar, M; Takeda, N; Umehara, H | 1 |
| Shirasaki, T; Soeda, F; Takahama, K; Yokomizo, K; Zhou, JR | 1 |
3 other study(ies) available for suplatast tosilate and histamine
| Article | Year |
|---|---|
Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Arylsulfonates; Caspase 1; Dermatitis, Atopic; Down-Regulation; Histamine; Immunoglobulin E; Interferon-gamma; Interleukin-4; Interleukin-5; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Animal; RNA, Messenger; Skin; Spleen; Sulfonium Compounds; Th2 Cells | 2006 |
Suplatast tosilate inhibits histamine signaling by direct and indirect down-regulation of histamine H1 receptor gene expression through suppression of histidine decarboxylase and IL-4 gene transcriptions.
Topics: Animals; Arylsulfonates; Down-Regulation; HeLa Cells; Histamine; Histidine Decarboxylase; Humans; Interleukin-4; Rats; Receptors, Histamine H1; RNA, Messenger; Signal Transduction; Sulfonium Compounds; Toluene 2,4-Diisocyanate; Transcription, Genetic | 2009 |
Direct Potentiation of Capsaicin Current by Histamine and Its Effect by Suplatast on Rat Trigeminal Ganglia Neurons.
Topics: Animals; Arylsulfonates; Capsaicin; Dose-Response Relationship, Drug; Drug Synergism; Female; Histamine; Male; Membrane Potentials; Neurons; Rats; Sulfonium Compounds; Trigeminal Ganglion | 2018 |